(OR) L’Oreal - Ratings and Ratios
Skincare, Makeup, Haircare, Perfumes, Hygiene Products
Description: OR L’Oreal
LOréal S.A. is a global cosmetics company that operates through four divisions: Professional Products, Consumer Products, Luxe, and Dermatological Beauty, offering a wide range of products including skincare, makeup, haircare, and perfumes. The companys diverse portfolio of brands includes well-known names such as LOréal Paris, Garnier, Maybelline, and Lancôme, among others.
With a presence in various distribution channels, including hair salons, e-commerce, travel retail, and department stores, LOréal S.A. has a strong global footprint. The companys products are sold worldwide, catering to a broad customer base. Key Performance Indicators (KPIs) such as revenue growth, brand recognition, and market share are crucial in evaluating the companys success.
To further analyze LOréal S.A.s performance, some key metrics to consider are: gross margin ratio, operating margin, and dividend yield. A high gross margin ratio indicates the companys ability to maintain pricing power and manage production costs. Operating margin is also a key indicator of the companys profitability, reflecting its ability to manage operating expenses. Additionally, dividend yield is an important consideration for income-seeking investors, indicating the return on investment in the form of dividends.
From a financial perspective, LOréal S.A.s market capitalization of approximately €197 billion and a Return on Equity (RoE) of 26.19% suggest a significant presence in the personal care products industry. The companys P/E ratio of 30.96 and forward P/E of 28.41 indicate the markets expectations for future growth. These metrics, combined with the companys brand portfolio and global reach, provide a comprehensive view of LOréal S.A.s position in the market.
OR Stock Overview
| Market Cap in USD | 247,560m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
OR Stock Ratings
| Growth Rating | 42.1% |
| Fundamental | 74.8% |
| Dividend Rating | 63.9% |
| Return 12m vs S&P 500 | -11.1% |
| Analyst Rating | - |
OR Dividends
| Dividend Yield 12m | 1.84% |
| Yield on Cost 5y | 2.72% |
| Annual Growth 5y | 11.38% |
| Payout Consistency | 99.9% |
| Payout Ratio | 61.3% |
OR Growth Ratios
| Growth Correlation 3m | 56.4% |
| Growth Correlation 12m | 42.2% |
| Growth Correlation 5y | 53.8% |
| CAGR 5y | 9.19% |
| CAGR/Max DD 5y | 0.31 |
| Sharpe Ratio 12m | -0.16 |
| Alpha | -2.49 |
| Beta | 0.105 |
| Volatility | 21.89% |
| Current Volume | 198.9k |
| Average Volume 20d | 215.4k |
| Stop Loss | 390.2 (-3%) |
| Signal | -0.39 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (11.21b TTM) > 0 and > 6% of Revenue (6% = 4.61b TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -2.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 2.39% (prev 3.46%; Δ -1.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.21 (>3.0%) and CFO 11.79b > Net Income 11.21b (YES >=105%, WARN >=100%) |
| Net Debt (4.44b) to EBITDA (11.84b) ratio: 0.38 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (605.3m) change vs 12m ago 12.74% (target <= -2.0% for YES) |
| Gross Margin 73.80% (prev 73.89%; Δ -0.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 141.9% (prev 79.42%; Δ 62.49pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 25.40 (EBITDA TTM 11.84b / Interest Expense TTM 400.6m) >= 6 (WARN >= 3) |
Altman Z'' 4.13
| (A) 0.03 = (Total Current Assets 16.47b - Total Current Liabilities 14.64b) / Total Assets 56.35b |
| (B) 0.40 = Retained Earnings (Balance) 22.55b / Total Assets 56.35b |
| (C) 0.19 = EBIT TTM 10.18b / Avg Total Assets 54.10b |
| (D) 1.28 = Book Value of Equity 29.69b / Total Liabilities 23.22b |
| Total Rating: 4.13 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 74.75
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 3.05% = 1.53 |
| 3. FCF Margin 8.65% = 2.16 |
| 4. Debt/Equity 0.21 = 2.48 |
| 5. Debt/Ebitda 0.59 = 2.23 |
| 6. ROIC - WACC 14.02% = 12.50 |
| 7. RoE 37.43% = 2.50 |
| 8. Rev. Trend -13.75% = -0.69 |
| 9. Rev. CAGR 7.61% = 0.95 |
| 10. EPS Trend 3.29% = 0.08 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of OR shares?
Over the past week, the price has changed by +0.41%, over one month by +7.70%, over three months by +9.80% and over the past year by +4.66%.
Is L’Oreal a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OR is around 390.64 EUR . This means that OR is currently overvalued and has a potential downside of -2.91%.
Is OR a buy, sell or hold?
What are the forecasts/targets for the OR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 387.6 | -3.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 426.6 | 6% |
OR Fundamental Data Overview
Market Cap EUR = 212.53b (212.53b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 1.83b EUR (last fiscal year)
P/E Trailing = 34.6766
P/E Forward = 30.8642
P/S = 4.848
P/B = 6.7914
P/EG = 4.4361
Beta = 0.834
Revenue TTM = 76.78b EUR
EBIT TTM = 10.18b EUR
EBITDA TTM = 11.84b EUR
Long Term Debt = 5.19b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.85b EUR (from shortTermDebt, last fiscal year)
Debt = 7.04b EUR (Calculated: Short Term 1.85b + Long Term 5.19b)
Net Debt = 4.44b EUR (from netDebt column, last fiscal year)
Enterprise Value = 217.74b EUR (212.53b + Debt 7.04b - CCE 1.83b)
Interest Coverage Ratio = 25.40 (Ebit TTM 10.18b / Interest Expense TTM 400.6m)
FCF Yield = 3.05% (FCF TTM 6.64b / Enterprise Value 217.74b)
FCF Margin = 8.65% (FCF TTM 6.64b / Revenue TTM 76.78b)
Net Margin = 14.60% (Net Income TTM 11.21b / Revenue TTM 76.78b)
Gross Margin = 73.80% ((Revenue TTM 76.78b - Cost of Revenue TTM 20.11b) / Revenue TTM)
Tobins Q-Ratio = 7.33 (Enterprise Value 217.74b / Book Value Of Equity 29.69b)
Interest Expense / Debt = 0.19% (Interest Expense 13.6m / Debt 7.04b)
Taxrate = 23.90% (from yearly Income Tax Expense: 2.02b / 8.43b)
NOPAT = 7.75b (EBIT 10.18b * (1 - 23.90%))
Current Ratio = 1.13 (Total Current Assets 16.47b / Total Current Liabilities 14.64b)
Debt / Equity = 0.21 (Debt 7.04b / last Fiscal Year total Stockholder Equity 33.13b)
Debt / EBITDA = 0.59 (Net Debt 4.44b / EBITDA 11.84b)
Debt / FCF = 1.06 (Debt 7.04b / FCF TTM 6.64b)
Total Stockholder Equity = 29.95b (last 4 quarters mean)
RoA = 19.89% (Net Income 11.21b, Total Assets 56.35b )
RoE = 37.43% (Net Income TTM 11.21b / Total Stockholder Equity 29.95b)
RoCE = 28.97% (Ebit 10.18b / (Equity 29.95b + L.T.Debt 5.19b))
RoIC = 20.22% (NOPAT 7.75b / Invested Capital 38.31b)
WACC = 6.20% (E(212.53b)/V(219.57b) * Re(6.40%)) + (D(7.04b)/V(219.57b) * Rd(0.19%) * (1-Tc(0.24)))
Shares Correlation 5-Years: 0.0 | Cagr: 2.07%
Discount Rate = 6.40% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 76.68% ; FCFE base≈7.01b ; Y1≈6.33b ; Y5≈5.46b
Fair Price DCF = 184.9 (DCF Value 98.60b / Shares Outstanding 533.2m; 5y FCF grow -12.16% → 3.0% )
Revenue Correlation: -13.75 | Revenue CAGR: 7.61%
Rev Growth-of-Growth: -86.88
EPS Correlation: 3.29 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 59.74